Skip to main content
. 2020 Sep 9;12(9):2567. doi: 10.3390/cancers12092567

Figure 6.

Figure 6

Schematic overview of the exotic CAR formats used in clinical trials treating solid tumors. The number of clinical trials using a specific CAR format is indicated. Data was extracted from clinicaltrials.gov. TM = transmembrane domain, PD1 = programmed cell death protein 1, IL13 (E13Y) = mutated IL-13 optimized to bind IL-13Rα2, TE1 = promiscuous ErbB ligand derived from EGF and TGFα. The Motifolio Scientific Illustration Toolkit was used for the generation of parts of this figure.